Sheila Denton replaces Courtney Nelson Wills in the role | 1w
Pharmaceutical/Medical
Patrick Murphy replaces John Mitchell as group’s top lawyer | 2w
Los Angeles-based Kimberly Branscome joins as co-chair of Gibson Dunn’s product liability practice as firm expands litigation bench yet again | 2w
Michael Parini will join in August, replacing former CLO Susan Alexander who left the company at the end of May | 2mos
This comparative guide offers a practical overview of the enforcement of judgments and arbitration awards across multiple jurisdictions. | 4mos
Kirkland advises Vertex in $10bn acquisition of Paul Weiss- and Morrison & Foerster-repped Crinetics | 3mos
Ashurst Perkins Coie launches with more than 950 partners across 52 global offices | 3mos
Davis Polk and Slaughter and May advise GSK as Ropes & Gray counsels target Nuvalent | 3mos
Sarah Karlgaard replaces GC Nancy Evert, who is leaving the business after more than two decades | 4mos
Adam Golden joins the drug-maker as it moves closer to becoming a publicly-traded company | 5mos
Felecia Ettenberg is set to replace Elizabeth Grammer, who is retiring | 5mos
Lanesha Minnix replaces Michelle Quinn, who joined Medtronic last year | 7mos
George Lyford brings more than 15 years of legal leadership experience in the healthcare industry | 7mos
Matthew Maletta replaces Brian Romano, who is leaving the company after more than 20 years | 7mos
David Wood succeeds Dwight Moxie in the role | 8mos
Sudo Biosciences, PepGen and Tonix Pharmaceuticals all recruit experienced biotech specialists | 9mos
Richard Hoffman replaces Sheila Denton in the role | 10mos
Agnieszka Gallagher succeeds Stillman Hanson, who is leaving the company | 10mos
Gibson Dunn also advised Merck on its $10bn acquisition of Verona Pharma earlier this year | 10mos
Under the leadership of three co-chairs, the firm will capitalise on growing demand in the health, science and luxury sectors | 11mos
Calls Ionis’ claims “baseless” in legal battle at the US courts | 1yr